FDA Adverse Event Malfunction Summary report: N

MMT-715 PARADIGM INSULIN PUMP

MDR report key: 6583344 · Received May 22, 2017

Report

Report Number
2032227-2017-20567
Event Type
Malfunction
Date Received
May 22, 2017
Date of Event
April 1, 2017
Report Date
May 22, 2017
Manufacturer
MEDTRONIC MINIMED
Product Code
LZG
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT DUE TO THE LIMITED SCOPE OF THE STUDY. RABBONE, I, ET AL. " INSULIN PUMP FAILURES IN (B)(4) CHILDREN WITH TYPE 1 DIABETES: RETROSPECTIVE 1-YEAR COHORT STUDY" DIABET. MED. 2017 34:5 (621-624).

Description of Event or Problem · 1

<P STYLE="MARGIN: 0IN 0IN 8PT;">IN A STUDY REGARDING INSULIN PUMP FAILURE AND/OR MALFUNCTION REQUIRING REPLACEMENT EVALUATED PUMP REPLACEMENT IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES USING INSULIN PUMP THERAPY. DATA WERE COLLECTED FOR PARTICIPANTS YOUNGER THAN 19 YEARS, STARTING INSULIN PUMP THERAPY BEFORE 31 DECEMBER 2013. IN TOTAL, 1574 OF 11 311 (13.9%) CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES WERE USING AN INSULIN PUMP: 29.2% PRODUCT A, 9.4% MEDTRONIC (B)(4) 715/515¿, 34.3% MEDTRONIC MINIMED VEO, 24.3% PRODUCT D AND 2.8% OTHER MODELS. 2013, 0.165 INSULIN PUMP REPLACEMENTS PER PATIENT YEAR(11.8% DUE TO PUMP FAILURE/MALFUNCTION AND 4.7% DUE TO ACCIDENTAL DAMAGE) WERE RECORDED. THE STUDY CONCLUDED THAT INSULIN PUMP FAILURE/MALFUNCTION AND CONSEQUENT REPLACEMENT ARE ALIGNED WITH RATES PREVIOUSLY REPORTED AND HIGHER IN MORE SOPHISTICATED PUMP MODELS.</P>.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
362134 MMT-715 PARADIGM INSULIN PUMP PUMP, INFUSION, INSULIN LZG MEDTRONIC MINIMED MMT-715

Patients

Seq Age Sex Outcome Treatment
1